Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/1999
11/18/1999CA2328492A1 Human deadenylating nuclease, its preparation and use
11/18/1999CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999CA2328403A1 Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
11/18/1999CA2328130A1 Moraxella catarrhalis proteins
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/18/1999CA2327548A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999CA2327354A1 Human apoptosis associated proteins
11/18/1999CA2327351A1 Cell signaling proteins
11/17/1999EP0957172A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
11/17/1999EP0957167A1 Production of heterodimeric human fertility hormones
11/17/1999EP0957166A1 HUMANIZED IMMUNOGLOBULIN REACTING SPECIFICALLY WITH Fas LIGAND OR ACTIVE FRAGMENTS THEREOF AND REGION INDUCING APOPTOSIS ORIGINATING IN Fas LIGAND
11/17/1999EP0957162A1 Biological viral material obtained from a multiple sclerosis-associated virus strain infected cell line
11/17/1999EP0956506A1 Treatment and diagnosis of cancer
11/17/1999EP0956357A1 Invertase inhibitor
11/17/1999EP0956351A1 A tumor necrosis factor related ligand
11/17/1999EP0956350A1 Human chloride channel protein (hccp)
11/17/1999EP0956339A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
11/17/1999EP0956338A1 Novel host cells and methods of producing proteins
11/17/1999EP0956304A1 Dendritic cell-specific antibodies
11/17/1999EP0956302A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
11/17/1999EP0956298A1 Snrnp sm proteins
11/17/1999EP0956291A1 Dna encoding galanin galr3 receptors and uses thereof
11/17/1999EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses
11/17/1999EP0956032A1 Proteins and compositions for modulating mitosis
11/17/1999EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999EP0955804A1 Expression of globin proteins in plants
11/17/1999EP0955803A1 Plant retroviral polynucleotides and methods for use thereof
11/17/1999EP0805871B1 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen
11/17/1999EP0792886B1 Novel peptide and therapeutic agent
11/17/1999CN1235639A Reconstituted human anti-HM1.24 antibody
11/17/1999CN1235635A Extracellent expression of cellulose binding domains (CBD) using bacillus
11/17/1999CN1235555A Compounds and methods for treatment and diagnosis of mycobacterial infections
11/17/1999CN1235513A Nucleic acid and amino acid sequences ralating to helicobacter pylori and vaccine compositions thereof
11/17/1999CN1046550C Peptide production
11/16/1999US5986170 Murine model for human carcinoma
11/16/1999US5986079 Expression of pace in host cells and methods of use thereof
11/16/1999US5986076 A conjugate is formed by bonding a bioreactive agent to the therapeutic agent with a bond that is selectively cleavable with electromagnetic radiation; useful for controlled release of drugs to treat the disorder
11/16/1999US5986073 Acidification and precipitation of somatotropins
11/16/1999US5986072 Coupling to glycidyl methacrylate-styrene copolymer through spacers
11/16/1999US5986069 Human haemopoietic maturation factor polypeptides
11/16/1999US5986068 Luetinizing hormone, follicle stimulating hormone, thyroid stimulating hhormone and chronic gonadotropin linked with oligosaccharide
11/16/1999US5986065 Antibodies for inhibiting blood coagulation and methods of use thereof
11/16/1999US5986064 Antibodies which specifically bind to human tumor-associated Kazal inhibitor-like polypeptide
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986055 CDK2 interactions
11/16/1999US5986052 Fusion polypeptide containing fragments of cartilage matrix protein and link protein
11/16/1999US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use
11/16/1999US5986049 Purification by applying a biological fluid to polypeptide support,washing, elution, fractionation and accumulation
11/16/1999US5986048 Process for obtaining insulin precursors having correctly bonded cystine bridges
11/16/1999US5985828 Screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies
11/16/1999US5985657 Nucleotide sequence coding for human il-1; expression vectors and host cells
11/16/1999US5985654 Gene which expresses a protein corresponding to the conserved exposed region of the m6 protein, a virulence factor of streptococcus; poxvirus such as vaccinia containing m6 gene used as vaccines against streptococcal infection
11/16/1999US5985646 Thermostable isolated polynucleotide encoding an enzyme wtih amidase activity; an enzyme having activity in the removal of arginine, phenylalanine or methionine from the n-terminal end of peptides in peptide or peptidomimetic synthesis
11/16/1999US5985642 Culturing primary chicken embryonic fibroblasts, passaging until senescence, concentrating to maintain confluence, isolating non-senescent cells, culturing for greater than 30 passages, introducing recombinant virus, isolating virus
11/16/1999US5985641 Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies
11/16/1999US5985640 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
11/16/1999US5985626 Schiff base
11/16/1999US5985619 Amplification of target nucleic acid
11/16/1999US5985615 Directed switch-mediated DNA recombination
11/16/1999US5985614 Polynucleotides encoding interleukin-19
11/16/1999US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses
11/16/1999US5985611 Culturing animal cells; transformation with gene expression; recovering
11/16/1999US5985610 Gene expression in host cell of conformational epitopes
11/16/1999US5985606 Human preprotachykinin B
11/16/1999US5985603 P2x receptor DNA and protein sequence
11/16/1999US5985600 Nucleic acid encoding delta opioid receptor
11/16/1999US5985597 DNA encoding prostaglandin receptor EP1
11/16/1999US5985589 Dna sequences
11/16/1999US5985588 Phagemid for antibody screening
11/16/1999US5985586 Methods for identifying compounds that modulate the activity of human N-methyl-D-aspartate receptors
11/16/1999US5985585 Competitive binding; detection
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985580 Antibodies which specifically bind to the thymokine lymphotactin
11/16/1999US5985562 Analyzing dna sample
11/16/1999US5985337 Process for preparing a protein hydrolysate from protein containing animal products
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985288 Outer membrane protein P1 and peptides of Haemophilus influenzae type B
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985281 Antibody directed enzyme prodrug therapy (adept) using a non-naturally occuring mutant form of a host enzyme, especially a mutant form of ribonuclease.
11/16/1999US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985278 Anti-αV-integrin monoclonal antibody
11/16/1999US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases.
11/16/1999US5985267 Protein toxins active against lepidopteran pests
11/16/1999CA2088600C Herpes simplex virus vp16 vaccines
11/16/1999CA2064815C Therapeutic heterocyclic compounds
11/16/1999CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates
11/16/1999CA1340823C Insulin precursors, process for their preparation and process for the preparation of human insulin
11/13/1999CA2248987A1 Novel compounds
11/11/1999WO1999057565A2 Methods for diagnosing and evaluating cancer
11/11/1999WO1999057302A1 Process for producing protein hydrolyzate
11/11/1999WO1999057292A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057280A2 Neisseria meningitidis antigens and compositions
11/11/1999WO1999057279A1 Plasmid for gene expression in pichia ciferrii and transformation method using the same
11/11/1999WO1999057274A1 Human protease associated proteins
11/11/1999WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999WO1999057270A2 Human receptor molecules
1 ... 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 ... 1125